NuVasive | NUVA


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Abbott 100.78 -0.88 -0.87% -8.07%
AtriCure 47.86 -0.96 -1.97% 22.09%
Baxter International 41.34 -0.80 -1.90% -42.61%
Becton, Dickinson and Co. 249.50 -2.73 -1.08% 0.07%
Boston Scientific 51.07 0.37 0.73% 34.50%
Cooper Companies 349.79 -1.00 -0.29% 3.77%
Dexcom 121.13 1.42 1.19% 63.44%
Edwards Lifesciences 83.96 0.48 0.58% -10.34%
Globus Medical 55.91 -0.17 -0.30% -7.66%
Haemonetics 88.33 0.58 0.66% 36.29%
Hologic 78.18 -0.64 -0.81% 6.11%
Integra LifeSciences 40.95 -0.30 -0.73% -31.58%
Inogen 10.68 -0.48 -4.30% -59.22%
Intuitive Surgical 310.82 3.58 1.17% 51.42%
J&J 160.26 1.74 1.10% -7.74%
Medtronic 83.10 0.21 0.25% -10.39%
Merit Medical Systems 84.26 -0.98 -1.15% 44.21%
NuVasive 39.63 -0.02 -0.05% -24.25%
Orthofix International 19.86 -0.08 -0.40% -25.51%
Insulet 281.34 2.54 0.91% 28.28%
Stryker 276.77 -1.20 -0.43% 27.90%
Teleflex 238.56 -1.53 -0.64% -12.26%
Tandem Diabetes Care 24.18 -0.63 -2.54% -61.48%
Zimmer Biomet Holdings 135.29 2.22 1.67% 17.61%

Indexes Price Day Year
USND 13239 133.63 1.02% 12.63%
US2000 1881 -7.67 -0.41% 1.62%
US400 2557 -11.33 -0.44% 3.59%

NuVasive

NuVasive traded at $39.63 this Thursday June 8th, decreasing $0.02 or 0.05 percent since the previous trading session. Looking back, over the last four weeks, NuVasive lost 4.28 percent. Over the last 12 months, its price fell by 24.25 percent. Looking ahead, we forecast NuVasive to be priced at 38.28 by the end of this quarter and at 35.04 in one year, according to Trading Economics global macro models projections and analysts expectations.

NuVasive, Inc. is a developer of specialty spinal implants into a global medical technology company that is delivering integrated solutions for spine surgery. The Company's portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, and intraoperative neuromonitoring technology and service offerings. The Company's surgical access instruments include its Maxcess integrated split-blade retractor system. The Company's neuromonitoring software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support. The Company's Advanced Materials Science portfolio of specialized spinal implants is designed to advance spinal fusion by improving the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone (PEEK).